Share this post on:

Product Name :
Voclosporin

Search keywords :
Voclosporin

drugId :
null

Target Vo:
Calcineurin

Target Vo Short Name :
Calcineurin

Moa_Name:
Calcineurin inhibitors

First Approval Country :
United States

First Approval Date Filter:
2021

Origin Company_Name :
Aurinia

Active Company_Name :
3sbio Inc

Active Indication_Name:
Lupus Nephritis

In Active Indication_Name:
Glomerulosclerosis, Focal Segmental

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CNPase Antibody
Glucocorticoid Receptor alpha Antibody
Peroxiredoxin 1 Antibody (YA692): Peroxiredoxin 1 Antibody (YA692) is a non-conjugated and Mouse origined monoclonal antibody about 22 kDa, targeting to Peroxiredoxin 1 (6A6). It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related